Company news
Fusion Antibodies PLC news in 2026
Fusion Antibodies PLC's news releases, calls and decks from 2026, newest first.
Further contract with returning client
November 6, 2026
Contract win
October 22, 2026
Result of AGM
October 15, 2026
AGM statement H1 trading and research update
October 15, 2026
Launch of new customer-focused website
October 5, 2026
REPLACEMENT: Final Results
September 15, 2026
Grant of Canadian Patent for OptiMAL
September 9, 2026
Notice of acceptance of patent in Australia
August 6, 2026
Notice of allowance of patent in Canada
June 22, 2026
Update on grant-funded DR5 project
June 15, 2026
Exercise of options and total voting rights
June 2, 2026
Grant of patent in Japan
May 11, 2026
Antibody IP transfer agreement
March 30, 2026
Holding(s) in Company
February 4, 2026
Total Voting Rights
January 30, 2026
Issue of Director Shares
January 27, 2026
Placing and Subscription to raise approx £1.4m
January 27, 2026